SCHEMBL6312583

SCHEMBL6312583

CCOC(=O)C(C(C)=O)C1C=CCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
USP2 O75604 1/20 0.37
ALOX15 P16050 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TSHR P16473 3/20 0.36
PSMB11 A5LHX3 5/20 0.35
PSMA7 O14818 5/20 0.35
PSMB1 P20618 5/20 0.35
PSMA1 P25786 5/20 0.35
PSMA2 P25787 5/20 0.35
PSMA3 P25788 5/20 0.35
PSMA4 P25789 5/20 0.35
PSMB8 P28062 5/20 0.35
PSMB9 P28065 5/20 0.35
PSMA5 P28066 5/20 0.35
PSMB4 P28070 5/20 0.35
PSMB6 P28072 5/20 0.35
PSMB5 P28074 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10835660 0.92 L3MBTL1 (0.41) ALDH1A1NPSR1L3MBTL1USP2ALOX15
SCHEMBL5859549 0.82 ALDH1A1 (0.44) ALDH1A1NPSR1L3MBTL1USP2ALOX15
SCHEMBL10337081 0.79 PSMB11 (0.34) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL28649391 0.77 RAB9A (0.33) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL10394014 0.76 ALDH1A1 (0.38) ALDH1A1NPSR1L3MBTL1USP2ALOX15
SCHEMBL10394018 0.76 ALDH1A1 (0.38) ALDH1A1NPSR1L3MBTL1USP2ALOX15
SCHEMBL15973796 0.76 THRB (0.39) ALDH1A1NPSR1TSHRPSMB11PSMA7
SCHEMBL21531500 0.76 THRB (0.39) ALDH1A1NPSR1TSHRPSMB11PSMA7
SCHEMBL10076680 0.76 THRB (0.39) ALDH1A1NPSR1TSHRPSMB11PSMA7
SCHEMBL13235977 0.74 PSMB1 (0.38) PSMB11PSMA7PSMB1PSMA1PSMA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 ALDH1A1 2550/4885NPSR1 1531/4885L3MBTL1 3913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.